Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Tumor antigens presented to T helper lymphocytes--critical components of the cancer vaccine].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke - 20 Oct 2001

Bartnes K

Abstract excerpt

BACKGROUND: Due to acquired mutations, the protein composition of malignant tumours is distinct from that of normal cells to which the immune system is tolerant. Mobilisation of the patient's immune system against malignant cells remaining after conventional treatment is an attractive therapeutic option since lymphocytes respond with high sensitivity and specificity to non-self. MATERIAL AND METHODS: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Histocompatibility Antigens Class II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocyte Activation

Share to Mutation

Share to Neoplasms

Share to T-Lymphocytes, Helper-Inducer

Share to Vaccines, Subunit

Source

Identifiers

PMID: 11715777

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Tumor antigens presented to T helper lymphocytes--critical components of the cancer vaccine].PMID 11715777Read ↗

Vaccination with T cell-defined antigens.Semantic proximity Read ↗

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.Semantic proximity Read ↗

MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccinesSemantic proximity Read ↗

About human tumor antigens to be used in immunotherapy.Semantic proximity Read ↗

Identification of tumour-associated T-cell epitopes for vaccine development.Semantic proximity Read ↗

Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.Semantic proximity Read ↗

Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.Semantic proximity Read ↗

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.Semantic proximity Read ↗

Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention.Semantic proximity Read ↗

Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.Semantic proximity Read ↗

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation.Semantic proximity Read ↗

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.